|
|
Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19).
Clarisse Eveno
,
Antoine Adenis
,
Olivier Bouche
,
Karine Le Malicot
,
Vincent Hautefeuille
et al.
Article dans une revue
hal-03597236v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Christophe Locher
,
Blaise Batumona
,
Pauline Afchain
,
Nicolas Carrère
,
Emmanuelle Samalin
et al.
Article dans une revue
hal-01708040v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot
,
Cecile Badoual
,
Magali Terme
,
Florence Castan
,
Aurelie Cazes
et al.
Article dans une revue
hal-01579145v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
Guillaume Portier
,
Dominique Elias
,
Olivier Bouche
,
Philippe Rougier
,
Jean-François Bosset
et al.
Article dans une revue
hal-00485672v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD‐NADEGE cohort study of 347 patients
Thomas T. Aparicio
,
Julie Henriques
,
Sylvain Manfredi
,
David Tougeron
,
Olivier Bouche
et al.
Article dans une revue
hal-02532893v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|